In recent years, regulatory investigators
have observed an increase in violations
involving data integrity (1). Inconsistencies
related to data integrity pose risks to
product safety, effectiveness and quality.
At the same time, pharmaceutical manufacturing
is growing ever more digitized,
raising the criticality of data integrity even
further. In light of these technological
changes, it pays for companies to invest in
a data integrity strategy.